SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is trending as its community leverages high social engagement and steady, organic growth to push toward new market cap milestones. Supporters are actively discussing their long-term conviction in the project, emphasizing its transparency and community-driven approach as key differentiators in the memecoin market.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

The Buttcoin community is rallying behind a long-standing narrative that positions the token as a cultural counterpoint to traditional assets, driven by its 2011 origin story and status as an early pioneer in the parody coin space. Supporters are actively discussing a transition toward a more formal ecosystem, emphasizing the coin's historical persistence and growing adoption as primary catalysts for its future potential.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost is trending as community members debate its potential as a privacy-focused utility token on the Solana network versus persistent accusations of it being a pump-and-dump scheme. Discussions are polarized between investors promoting it as an undervalued gem with upcoming project milestones and critics labeling it a slow rug pull.

Vanguard World Fund - Vanguard Emerging Markets Ex-China ETF

Investors are increasingly utilizing this ETF as a strategic alternative to gain exposure to emerging markets while intentionally avoiding Chinese equities. Market participants are actively debating the merits of geographical diversification in response to heightened geopolitical volatility and concerns regarding systemic stability in international markets.

Invitation Homes, Inc. engages in the acquisition, renovation, leasing, and operation of single-family homes as rental properties, including single-family homes in planned unit developments. Its services include property management, selection of homes, maintenance program, and online payment. The company was founded by Marcus Ridgway, Dallas Tanner, and Brad Greiwe in 2012 and is headquartered in Dallas, TX.

Invitation Homes Inc

Invitation Homes is garnering attention as the broader housing sector faces intense scrutiny over the impact of institutional ownership on home affordability. Investors are closely monitoring its performance against a backdrop of potential policy shifts, fluctuating interest rates, and internal growth initiatives like new development partnerships.

Braiin Ltd. is an Australian technology company, which engages in developing a precision agriculture technology platform that provides farm management services. It operates through the following geographical segments: Australia, Sri Lanka, and U.S.A. The company was founded by Natraj Balasubramanian and Darren McVean on July 4, 2022 and is headquartered in Subiaco, Australia.

Braiin Ltd

Braiin Ltd is attracting intense retail interest amid reports of a forward stock split and its participation in high-profile AI-focused virtual conferences. The community is sharply divided, with some traders highlighting the potential for volatile price swings typical of low-float, AI-linked names, while others warn of a potential pump-and-dump setup due to concerns over valuation and share structure.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is gaining significant traction on the Solana network, with the community highlighting its long-term project viability, consistent daily activity, and a voluntary supply-locking mechanism. Supporters are actively focused on the project's 'PvE' narrative, emphasizing deep conviction, doxxed leadership, and steady growth over short-term hype.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors highlight its unique "phygital" strategy, which leverages a massive retail presence through major toy retailers alongside recent digital integrations like the Pudgy World game. Community members remain focused on long-term accumulation, often citing the project's brand power and utility-driven partnerships as key differentiators that could sustain momentum despite broader market volatility.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to anticipation of the CHOPIN trial data, which is set to be presented as a late-breaking abstract at ESMO. While the community is frustrated by recent stock volatility and revenue guidance adjustments, sentiment remains highly focused on the potential for clinical trial success to expand the Hepzato Kit's standard-of-care position and drive long-term value.

Fortinet, Inc. provides cybersecurity solutions to a variety of businesses, such as enterprises, communication service providers, government organizations, and small to medium-sized businesses. Its product portfolio includes network security, secure access service edge, enterprise networking, security operations, application security, and operational technology. The company was founded by Ken Xie and Michael Xie in October 2000 and is headquartered in Sunnyvale, CA.

Fortinet Inc

Fortinet is trending as investors weigh strong Q3 earnings beats and raised full-year guidance against recent stock volatility and broader cybersecurity sector pressures. While some market participants are taking advantage of price dips to accumulate shares, others remain cautious due to intense competition and lingering macroeconomic concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rapt Therapeutics (NASDAQ:RAPT) Receives Average Rating of "Hold" from Analysts

Rapt Therapeutics (NASDAQ:RAPT - Get Free Report) has been assigned an average rating of "Hold" from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. One...

Promising Small Cap Stocks To Follow Today - March 4th

Rapt Therapeutics, Actelis Networks, and Firefly Neuroscience are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly...

Top Pharmaceutical Stocks To Consider - March 4th

Eli Lilly and Company, Rapt Therapeutics, Novo Nordisk A/S, AbbVie, Pfizer, Bristol Myers Squibb, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

Top Medical Stocks To Research - March 4th

Eli Lilly and Company, UnitedHealth Group, Rapt Therapeutics, Novo Nordisk A/S, Moderna, AbbVie, and Boston Scientific are the seven Medical stocks to watch today, according to MarketBeat's stock...

Best Small Cap Stocks To Keep An Eye On - March 3rd

Mobix Labs, Rapt Therapeutics, and Vale are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with...

Pharmaceutical Stocks To Watch Today - March 3rd

Eli Lilly and Company, Novo Nordisk A/S, Rapt Therapeutics, AbbVie, Gilead Sciences, Bristol Myers Squibb, and Pfizer are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

Promising Medical Stocks To Consider - March 2nd

Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, Rapt Therapeutics, Novo Nordisk A/S, and Amgen are the seven Medical stocks to watch today, according to MarketBeat's stock...

Pharmaceutical Stocks To Add to Your Watchlist - March 2nd

Eli Lilly and Company, AbbVie, Novo Nordisk A/S, Rapt Therapeutics, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks...

Rapt Therapeutics (NASDAQ:RAPT) Sets New 1-Year High - Still a Buy?

Rapt Therapeutics (NASDAQ:RAPT) Sets New 1-Year High - Time to Buy...

Short Interest in Rapt Therapeutics (NASDAQ:RAPT) Drops By 30.5%

Rapt Therapeutics (NASDAQ:RAPT - Get Free Report) was the recipient of a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 2,242,149...

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.68	--	--	N/A
Q4 '25	-$0.87	--	--	N/A
Q3 '25	-$0.98	-$0.65	33.54%	BEAT
Q2 '25	-$0.74	-$0.65	12.20%	BEAT
Q1 '25	-$0.14	-$0.64	-370.25%	MISSED

RAPT
RAPT Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest RAPT News

RAPTRAPT Therapeutics Inc